The tumor metabolome

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 1149-1154

  Mazurek, Sybille ^a   Eigenbrodt, Erich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Glutaminolysis; Glycolysis; NAD; Tumor M2 PK; Tumor therapy

Indexed keywords

CISPLATIN; GLUCOSE; LACTATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXYGEN; PROTEOME; PYRUVATE KINASE; TUMOR MARKER;

APOPTOSIS; CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; ENZYME ACTIVITY; GENOMICS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REDUCTION; TUMOR; TUMOR GROWTH;

GENOME, HUMAN; GLUCOSE; GLUTAMINE; GLYCOLYSIS; HUMANS; ISOENZYMES; MODELS, BIOLOGICAL; NEOPLASMS; PYRUVATE KINASE;

EID: 0037561649     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Mazurek S, Zwerschke W, Jansen-Dürr P and Eigenbrodt E: Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene 20: 6891-6898, 2001.
2. Mazurek S, Grimm H, Boschek CB, Vaupel P and Eigenbrodt E: Pyruvate kinase type M2: a crossroad in the tumor metabolome. Brit J Nutr 87: 23-29, 2002.
3. Mazurek S, Lüftner D, Wechsel HW, Schneider J and Eigenbrodt E: Tumor M2-PK: a marker of the tumor metabolome. In: Tumor Markers-Pgysiology, Pathobiology, Technology and Clinical Applications. (Diamadis EP, Fritsche HA, Lilja H, Chan DW and Schwartz MK eds). Washington DC, AACC Press, 2002, 47, pp471-475.
4. Mazurek S, Boschek CB and Eigenbrodt E: The role of phospho-metabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 29: 315-330, 1997.
5. Eigenbrodt E and Glossmann H: Glycolysis - one of the keys to cancer. Trends Pharmacol Sci 1: 240-245, 1980.
6. Eigenbrodt E, Gerbracht U, Mazurek S, Presek P and Friis R: Carbohydrate metabolism and neoplasia: New perspectives for diagnosis and therapy. In: Biochemical and Molecular Aspects of Selected Cancers, 2 (Pretlow TG and Pretlow TP, eds). New York, Academic Press, 1994, pp 311-385.
7. Eigenbrodt E, Fister P and Reinacher M: New perspectives on carbohydrate metabolism in tumor cells. In: Regulation of Carbohydrate Metabolism (Beitner Red). Boca Raton, Fl, CRC Press, 1985, pp 141-179.
8. Mazurek S, Eigenbrodt E, Failing K and Steinberg P: Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells. J Cell Physiol 181: 136-146, 1999.
9. Mazurek S, Michel A and Eigenbrodt E: Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem 272: 4941-4952, 1997.
10. Mazurek S, Grimm H, Wilker S, Leib S and Eigenbrodt E: Metabolic characteristics of different malignant cancer cell lines. Anticancer Res 18: 3275-3282, 1998.
11. Eigenbrodt E, Kallinowski F, Ott M, Mazurek S and Vaupel P: Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Res 18: 3267-3274, 1998.
12. Mazurek S, Weisse G, Wüst G, Schäfer-Schwebel A, Eigenbrodt E and Friis RR: Energy metabolism in the involuting mammary gland. In Vivo 13: 467-478, 1999.
13. Weber G: Medical Progress. Enzymology of cancer cells. New England J Med 296: 486-551, 1977.
14. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL and Passonneau V: Control of glucose utilization in working perfused rat heart. J Biol Chem 269: 25502-25514, 1994.
15. Jackson RC, Lui MS, Boritzki TJ, Morris HP and Weber G: Purine and pyrimidine nucleotide patterns of normal, differentiating, and regenerating liver and heptomas in rats. Cancer Res 40: 1286-1291, 1980.
16. Weber G, Stubbs M and Morris HP: Metabolism of hepatomas of different growth rates in situ and during ischemia. Cancer Res 31: 2177-2183, 1971.
17. Steinberg P, Weiße G, Eigenbrodt E and Oesch F: Expression of L- and M2-pyruvate kinases in proliferating oval cells and cholangiocellular lesions developing in the livers of rats fed a methyl-deficient diet. Carcinogenesis 15: 125-127, 1994.
18. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H and Friis RR: Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. In: Critical Reviews in Oncogenesis (Perucho M ed). Boca Raton, Fl, CRC-Press, 3, 1992, pp 91-115.
19. Katz N, Immenschuh S, Gerbracht U, Eigenbrodt E, Föllmann W and Petzinger E: Hormone-sensitive carbohydrate metabolism in rat hepatocyte-hepatoma hybrid cells. Eur J Cell Biol 57: 117-123, 1992.
20. Wechsel HW, Petri E, Bichler K-H and Feil G: Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinase type M2 (Tu M2-PK). Anticancer Res 19: 2583-2590, 1999.
21. Lüftner D, Mesterharm J, Akrivakis C, Geppert R, Petrides PE, Wernecke K-D and Possinger K: Tumor M2 pyruvate kinase expression in advanced breast cancer. Anticancer Res 20: 5077-5082, 2000.
22. Schneider J, Morr H, Velcovsky H-G, Weisse G and Eigenbrodt E: Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases. Cancer Detection Prevention 24: 531-535, 2000.
23. Raïs B, Comin B, Puigjaner J, Brandes JL, Creppy E, Saboureau D, Ennamany R, Lee W-NP, Boros LG and Cascante M: Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett 456: 113-118, 1999.
24. Boros LG, Torday JS, Lim S, Bassillan S, Cascante M and Lee WN: Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60: 1183-1185, 2000.
25. McKeehan WL: Glycolysis, glutaminolysis and cell proliferation. Cell Biol Int Rep 6: 635-650, 1982.
26. Mazurek S, Grimm H, Oehmke M, Weisse G, Teigelkamp S and Eigenbrodt E: Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells. Anticancer Res 20: 5151-5154, 2000.
27. Mazurek S, Zwerschke W, Jansen-Dürr P and Eigenbrodt E: Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic enzyme complex. Biochem J 356: 247-256, 2001.
28. Mazurek S, Hugo F, Failing K and Eigenbrodt E: Studies of associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of p36. J Cell Physiol 167: 238-250, 1996.
29. Presek P, Reinacher M and Eigenbrodt E: Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus. FEBS Lett 242: 194-198, 1988.
30. Eigenbrodt E, Mazurek S and Friis RR: Double role of pyruvate kinase type M2 in the regulation of phosphometabolite pools. In: Cell Growth and Oncogenesis (Bannasch P, Kanduc D, Papa S and Tager JM eds). Basel/Switzerland, Birkhäuser Verlag, 1998, pp 15-30.
31. Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E and Jansen-Dürr P: Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA 96: 1291-1296, 1999.
32. Le Mellay V, Houben R, Troppmair J, Hagemann C, Mazurek S, Frey U, Beigel J, Weber C, Benz R, Eigenbrodt E and Rapp UR: Regulation of glycolysis by Rat protein serine/threonine kinases. Advan Enzyme Regul 42: 317-332, 2002.